维普期刊资源整合服务平台（V6.5）

46篇 您的检索式：作者名="Sabbagh MN"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Reduced risk of in- cident AD with elective statin use in a clinical trial cohort 显示文摘	Sparks DL Kryscio ILl Sabbagh MN	2008	Curr Alzheimer Res2008，5，4：	1
2	Donepezih potential neu- roprotective and disease- modifying effects显示文摘	Jacobson SA Sabbagh MN	2008	Ex- pert Opin Drug Metab Toxicol2008，4，10：	1
3	Parkinson's disese dementia: comparing patients with and without Alzheimer pathology 显示文摘	Sabbagh MN Adler CH Lahti TJ	2013	Nat Rev Neurosei2013，14，3：	1
4	Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease:results of the Alzheimer's Disease Cholesterol-Lowering Treatment trial 显示文摘	Sparks DL Connor D J Sabbagh MN	2006	Acta Neurol Scand Suppl2006，114，185：	1
5	Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT)trial显示文摘	SPARKS DL CONNOR DJ SABBAGH MN	2006	Acta Neurel Scand Suppl2006，185，：	1
6	Heterogeneous neuro- pathological findings in Parkinson's disease with mild cognitive impairment 显示文摘	Adler CH Caviness JN Sabbagh MN	2010	Acta Neuropathol2010，120，6：	1
7	Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary resuhs 显示文摘	Sparks DL Sabbagh MN Connor DJ	2005	Arch Neuro12005，62，5：	1
8	Atorvastatin therapy lowers cir- culating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD显示文摘	Sparks DL Sabbagh MN Connor D J	2005	Curt Alzheimet Res2005，2，3：	1
9	Atorvastatin for the treatment of mild to moderate Alzheimer disease:preliminary results显示文摘	Sparks DL Sabbagh MN Connor DJ	2005	Arch Neurol2005，62，5：	1
10	Reduced risk of incident AD with elective statin use in a clinical trial cohort显示文摘	Sparks DL Kryscio RJ Sabbagh MN	2008	Curr Alzheimer Res2008，5，4：	1
11	The nicotinic acetylcholine receptor, smoking, and Alzheimer's disease显示文摘	Sabbagh MN Lukas RJ Sparks DL	2002	J Alzheimers Dis2002，4，4：	1
12	Parkinson disease with dementia : comparing patients with and without Alzheimer pathology显示文摘	Sabbagh MN Adler CH Lahti TJ	2009	Alzheimer Dis Assoc Disord2009，23，：	1
13	Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's disease cholesterol - lowering treatment (ADCLT) trial 显示文摘	Sparks DL Connor DJ Sabbagh MN	2006	Acta Neurol Scand2006，114，185：	1
14	Reduced risk of incident AD with elective statin use in a clinical trial cohort显示文摘	Sparks DL Kryscio RJ Sabbagh MN		0，，：	1
15	Heterog eneousneuropathological findings in Parkinson' s disease with mild cognitive impair ment 显示文摘	Adler CH Caviness JN Sabbagh MN	2010	Acta Neuropathol2010，120，：	1
16	Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results显示文摘	Sparks DL Sabbagh MN Connor DJ	2005	Arch Neurol2005，62，：	1
17	Circulating cholesterol levels,apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer′s disease:results of the Alzheimer′s disease cholesterol-lowering treatment(ADCLT) trial显示文摘	Sparks DL Connor DJ Sabbagh MN	2006	Acta Neurol Scand2006，114，185：	1
18	Drug development for Alzheimers disease where are we now and where are we headed显示文摘	SABBAGH MN	2009	The Ameri can Journal of Geriatric Pharmaco-therapy2009，7，3：	1
19	Atorvastatin for the treatmentof mild to moderate Alzheimer disease : preliminary results 显示文摘	Sparks DL Sabbagh MN Connor DJ ef al	2005	Arch Neu-rol2005，62，5：	1
20	Reduced risk of incident AD with elective statin use in a clinical trial cohort显示文摘	Sparks DL Kryscio RJ Sabbagh MN		0，，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示